Concepedia

Publication | Open Access

Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers

DOIFull Paper Access

163

Citations

10

References

2008

Year

Fadi Braiteh, Andres O. Soriano, Guillermo Garcia‐Manero, David S. Hong, Marcella M. Johnson, Leandro de Pádua Silva, Hui Yang, Stefanie Alexander, Johannes Wolff, Razelle Kurzrock
Clinical Cancer Research

Abstract

The combination of 5-AZA and valproic acid is safe at doses up to 75 mg/m(2) for 5-AZA in patients with advanced malignancies.

References

YearCitations

Page 1